These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reappearance of effector T cells is associated with recovery from COVID-19. Odak I; Barros-Martins J; Bošnjak B; Stahl K; David S; Wiesner O; Busch M; Hoeper MM; Pink I; Welte T; Cornberg M; Stoll M; Goudeva L; Blasczyk R; Ganser A; Prinz I; Förster R; Koenecke C; Schultze-Florey CR EBioMedicine; 2020 Jul; 57():102885. PubMed ID: 32650275 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250 [TBL] [Abstract][Full Text] [Related]
6. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Zhang F; Gan R; Zhen Z; Hu X; Li X; Zhou F; Liu Y; Chen C; Xie S; Zhang B; Wu X; Huang Z Signal Transduct Target Ther; 2020 Aug; 5(1):156. PubMed ID: 32796814 [TBL] [Abstract][Full Text] [Related]
7. Immune dysfunction following COVID-19, especially in severe patients. Song CY; Xu J; He JQ; Lu YQ Sci Rep; 2020 Sep; 10(1):15838. PubMed ID: 32985562 [TBL] [Abstract][Full Text] [Related]
8. Dysregulated adaptive immune response contributes to severe COVID-19. Yu K; He J; Wu Y; Xie B; Liu X; Wei B; Zhou H; Lin B; Zuo Z; Wen W; Xu W; Zou B; Wei L; Huang X; Zhou P Cell Res; 2020 Sep; 30(9):814-816. PubMed ID: 32759967 [No Abstract] [Full Text] [Related]
9. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients. Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639 [TBL] [Abstract][Full Text] [Related]
10. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity. Han M; Xu M; Zhang Y; Liu Z; Li S; He T; Li J; Gao Y; Liu W; Li T; Chen Z; Huang X; Cheng G; Wang J; Dittmer U; Witzke O; Zou G; Li X; Lu M; Zhang Z Med Microbiol Immunol; 2020 Dec; 209(6):657-668. PubMed ID: 32860073 [TBL] [Abstract][Full Text] [Related]
11. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19. Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221 [TBL] [Abstract][Full Text] [Related]
12. Long-term infection of SARS-CoV-2 changed the body's immune status. Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373 [TBL] [Abstract][Full Text] [Related]
13. A dynamic COVID-19 immune signature includes associations with poor prognosis. Laing AG; Lorenc A; Del Molino Del Barrio I; Das A; Fish M; Monin L; Muñoz-Ruiz M; McKenzie DR; Hayday TS; Francos-Quijorna I; Kamdar S; Joseph M; Davies D; Davis R; Jennings A; Zlatareva I; Vantourout P; Wu Y; Sofra V; Cano F; Greco M; Theodoridis E; Freedman JD; Gee S; Chan JNE; Ryan S; Bugallo-Blanco E; Peterson P; Kisand K; Haljasmägi L; Chadli L; Moingeon P; Martinez L; Merrick B; Bisnauthsing K; Brooks K; Ibrahim MAA; Mason J; Lopez Gomez F; Babalola K; Abdul-Jawad S; Cason J; Mant C; Seow J; Graham C; Doores KJ; Di Rosa F; Edgeworth J; Shankar-Hari M; Hayday AC Nat Med; 2020 Oct; 26(10):1623-1635. PubMed ID: 32807934 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients. Niu X; Li S; Li P; Pan W; Wang Q; Feng Y; Mo X; Yan Q; Ye X; Luo J; Qu L; Weber D; Byrne-Steele ML; Wang Z; Yu F; Li F; Myers RM; Lotze MT; Zhong N; Han J; Chen L Front Immunol; 2020; 11():582010. PubMed ID: 33117392 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity. Wei J; Zhao J; Han M; Meng F; Zhou J J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811 [TBL] [Abstract][Full Text] [Related]
17. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection. Altmann DM; Boyton RJ Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32680954 [TBL] [Abstract][Full Text] [Related]
19. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595 [TBL] [Abstract][Full Text] [Related]
20. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. De Biasi S; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Gozzi L; Iannone A; Lo Tartaro D; Mattioli M; Paolini A; Menozzi M; Milić J; Franceschi G; Fantini R; Tonelli R; Sita M; Sarti M; Trenti T; Brugioni L; Cicchetti L; Facchinetti F; Pietrangelo A; Clini E; Girardis M; Guaraldi G; Mussini C; Cossarizza A Nat Commun; 2020 Jul; 11(1):3434. PubMed ID: 32632085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]